GREY:DGCRF - Post by User
Post by
ready2go1on Oct 16, 2012 4:32pm
259 Views
Post# 20490530
PCA3
PCA3 This company has never released any news and as I have said before, we continue to see selling secondary to fear of the unknown. I am expecting some type of news in the near term to jump start the stock and get us moving in the right direction. Why am I expecting?
all you have to do is look at the post that showed the MAYO clinic lab update for pca3. If this was not an important test, driven by patient demand, the hospitals and labs would not spend the money to train their staff, acquire the materials needed, and discuss testing options with patients. This is not the only lab update out there and I have seen several the past 30 days here in the U.S. plus there have been 4 new European labs that have began to offer the test last week. If pca3 was not an improtant test no one would go through the process to get the test approved to run at their labs; believe me, it takes someone on the other end demanding that the lab offer the test.
I'm frustrated just like everyone else; but I am looking at a move from 8% to 16% as a double in revenue, and many that I have spoken with are now using the test 3x more than they did prior to FDA approval. At some point, this will show up.